QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
NASDAQ:OFIX

Orthofix Medical Stock Forecast, Price & News

$45.68
+0.35 (+0.77 %)
(As of 03/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$44.74
Now: $45.68
$46.51
50-Day Range
$40.41
MA: $43.54
$47.87
52-Week Range
$22.11
Now: $45.68
$48.50
Volume70,535 shs
Average Volume93,360 shs
Market Capitalization$883.18 million
P/E Ratio38.07
Dividend YieldN/A
Beta1.12
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion as well as used as a therapeutic treatment for non-spinal appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Orthofix Medical logo

Headlines

Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results
February 26, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000
Employees1,055
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$459.95 million
Cash Flow$3.06 per share
Book Value$17.22 per share

Profitability

Net Income$-28,460,000.00

Miscellaneous

Market Cap$883.18 million
Next Earnings Date5/14/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.12 out of 5 stars

Medical Sector

944th out of 1,971 stocks

Surgical & Medical Instruments Industry

94th out of 169 stocks

Analyst Opinion: 1.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$45.68
+0.35 (+0.77 %)
(As of 03/8/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

Is Orthofix Medical a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Orthofix Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View analyst ratings for Orthofix Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Orthofix Medical?

Wall Street analysts have given Orthofix Medical a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Orthofix Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Friday, May 14th 2021.
View our earnings forecast for Orthofix Medical
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Friday, February, 26th. The medical device company reported $0.44 EPS for the quarter, topping the Zacks' consensus estimate of $0.15 by $0.29. Orthofix Medical had a net margin of 5.75% and a trailing twelve-month return on equity of 1.82%.
View Orthofix Medical's earnings history
.

How has Orthofix Medical's stock price been impacted by Coronavirus (COVID-19)?

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OFIX shares have increased by 48.9% and is now trading at $45.68.
View which stocks have been most impacted by COVID-19
.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical issued an update on its FY 2021 Pre-Market earnings guidance on Friday, February, 26th. The company provided earnings per share guidance of 0.45-0.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.99. The company issued revenue guidance of $445-460 million, compared to the consensus revenue estimate of $454.1 million.

What price target have analysts set for OFIX?

1 brokerages have issued 1 year price objectives for Orthofix Medical's stock. Their forecasts range from $39.00 to $39.00. On average, they anticipate Orthofix Medical's stock price to reach $39.00 in the next year. This suggests that the stock has a possible downside of 14.6%.
View analysts' price targets for Orthofix Medical
or view top-rated stocks among Wall Street analysts.

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the following people:
  • Mr. Jon C. Serbousek, Pres, CEO & Director (Age 60, Pay $1.78M)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 55, Pay $515.18k)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 56, Pay $508.05k)
  • Mr. Roberto Donadello, Sr. VP, Global Operations
  • Dr. James T. Ryaby B.A., Ph.D., Chemistry, Chief Scientific Officer (Age 62)
  • Mr. Tim McGuire, Chief Information Officer
  • Mr. Dan E. Yarbrough, VP of Investor Relations
  • Ms. Jill Mason, Chief Ethics & Compliance Officer
  • Ms. Suzanne Armstrong, VP of HR
  • Mr. Kevin J. Kenny, Pres of Global Spine Bus. (Age 56)

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical CEO Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among Orthofix Medical's employees.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.98%), Paradice Investment Management LLC (5.05%), Dimensional Fund Advisors LP (3.62%), Dimensional Fund Advisors LP (3.62%), Renaissance Technologies LLC (3.58%) and Royce & Associates LP (2.08%). Company insiders that own Orthofix Medical stock include Brad Mason, James F Hinrichs, Jon Carl Serbousek and Ronald A Matricaria.
View institutional ownership trends for Orthofix Medical
.

Which institutional investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Nuveen Asset Management LLC, JPMorgan Chase & Co., Renaissance Technologies LLC, Russell Investments Group Ltd., Paradice Investment Management LLC, Tudor Investment Corp Et Al, and THB Asset Management.
View insider buying and selling activity for Orthofix Medical
or view top insider-selling stocks.

Which institutional investors are buying Orthofix Medical stock?

OFIX stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Heartland Advisors Inc., BlackRock Inc., Royce & Associates LP, Healthcare of Ontario Pension Plan Trust Fund, Healthcare of Ontario Pension Plan Trust Fund, Canada Pension Plan Investment Board, and Public Employees Retirement System of Ohio. Company insiders that have bought Orthofix Medical stock in the last two years include James F Hinrichs, Jon Carl Serbousek, and Ronald A Matricaria.
View insider buying and selling activity for Orthofix Medical
or or view top insider-buying stocks.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $45.68.

How much money does Orthofix Medical make?

Orthofix Medical has a market capitalization of $883.18 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis.

How many employees does Orthofix Medical have?

Orthofix Medical employs 1,055 workers across the globe.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is www.orthofix.com.

Where are Orthofix Medical's headquarters?

Orthofix Medical is headquartered at 3451 Plano Parkway, Lewisville TX, 75056.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]


This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.